Alseres Pharmaceuticals Cash Flow Statement
View: Annual | Quarterly
| Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
Quarter Ending Mar 07 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | (4.3) | (4.3) | (4.1) | (5.1) | (11.0) |
| Net Investing Cash Flow | 1.3 | 1.2 | (2.3) | (0.0) | (0.0) |
| Net Financing Cash Flow | 5.0 | 0.1 | 9.9 | 6.0 | 11.0 |
| Net Change in Cash | 2.0 | (3.0) | 3.5 | 0.8 | 0.0 |
| Depreciation & Amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Capital Expenditures | 0.0 | 0.0 | 0.0 | (0.1) | (0.0) |
| Cash Dividends Paid | -- | -- | -- | -- | -- |





